Skip to content

The impact of neuromuscular relaxation and nociception guided anaesthesia on hemodynamic variables during abdominal laparoscopic surgery: a strategy trial.

The impact of neuromuscular relaxation and nociception guided anaesthesia on hemodynamic variables during abdominal laparoscopic surgery: a strategy trial. - RELAX-LAP

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52953
Enrollment
50
Registered
2019-08-07
Start date
2020-12-08
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesie, laparoscopie anesthesia

Interventions

Patients in this group will receive deep NMB, aimed at PTC 1-2 during the entire procedure. The NMB will be maintained with a continuous infusion of rocuronium and reversed at the end with sugammade

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: ASA 1-3 Age > 18 Scheduled for laparoscopic or robotic abdominal surgery Ability to give oral and written consent

Exclusion criteria

Exclusion criteria: Known or suspected neuromuscular disorders impairing neuromuscular function; Allergies to muscle relaxants, anesthetics or narcotics; A (family) history of malignant hyperthermia; Women who are or may be pregnant; Preexisting cardiac disease (any); Untreated or uncontrolled hypertension; COPD gold 3 or higher Any contradictions for TEE: Preexistent esophageal pathology (stricture, tumor, diverticulum) Any increased risk factor for upper gastro intestinal tract bleed: History of GI surgery; History of GI bleed; Esophageal varices; Gastric or esophageal inflammation; Severe thrombocytopenia (less than 50k) or severely elevated INR (>4).

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure at 30 minutes after installation of the pneumoperitoneum

Secondary

MeasureTime frame
Mean arterial pressure at all other time points Left ventricular ejection fraction, stroke volume, systolic and diastolic function, afterload and cardiac output Stroke volume variation Systemic vascular resistance Haemodynamic instability score

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)